Today: 22 March 2026
Subscribe
Browse Category

Dividends 30 October 2025 - 10 November 2025

Barrick Mining (B) Hikes Dividend 25% and Adds $500M Buyback as Record Q3 Cash Flow Lifts Shares

Barrick Mining (B) Hikes Dividend 25% and Adds $500M Buyback as Record Q3 Cash Flow Lifts Shares

Barrick Mining raised its base dividend 25% to $0.125 per share and expanded its share buyback by $500 million after reporting record Q3 operating and free cash flow. Net earnings for the quarter reached $1.3 billion on revenue of $4.1 billion. Gold production totaled 829,000 ounces, while copper output was 55,000 tonnes. Shares rose nearly 4% in premarket trading.
10 November 2025
····
DuPont (DD) Today: Citi Lifts Price Target to $47 as “New DuPont” Sets $0.20 Dividend, $2B Buyback After Qnity Spin

DuPont (DD) Today: Citi Lifts Price Target to $47 as “New DuPont” Sets $0.20 Dividend, $2B Buyback After Qnity Spin

Citi raised its DuPont target to $47 and kept a “Buy” rating after the company’s Qnity Electronics spinoff and new $0.20 quarterly dividend. DuPont authorized a $2 billion share repurchase, including a $500 million accelerated buyback. Q3 net sales rose 7% to $3.07 billion, with adjusted EPS at $1.09. Qnity now trades as NYSE: Q and joined the S&P 500.
9 November 2025
···
PayPal (PYPL) Today — Nov. 9, 2025: Antitrust Win, Dividend Countdown, and AI Checkout Momentum

PayPal (PYPL) Today — Nov. 9, 2025: Antitrust Win, Dividend Countdown, and AI Checkout Momentum

A U.S. judge dismissed a nationwide antitrust suit against PayPal’s merchant rules, giving plaintiffs until Dec. 12 to amend. PayPal reported Q3 revenue of $8.4 billion and raised its full-year outlook, launching a $0.14 quarterly dividend. Institutional investors trimmed positions. PayPal also announced a partnership with OpenAI to integrate payments into ChatGPT.
9 November 2025
····
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth (UNH) premarket: Dividend set, UBS talk at 8:45 a.m. ET, raised guidance — what to watch on November 10, 2025

UnitedHealth Group will appear at the UBS Global Healthcare Conference Monday after raising its 2025 guidance to at least $14.90 GAAP EPS and declaring a $2.21 quarterly dividend. The company closed its $3.3 billion Amedisys acquisition in August. About 78% of Medicare Advantage members are now in 4-star or higher plans. DOJ matters and 2026 medical cost trends remain under review.
9 November 2025
···
Mastercard Stock Climbs on New Tech, Stablecoin Push and Partnerships

Mastercard (MA) Today: Poland Hubs, Live Nation SA, Upward Deal, RS2 Issuing & Dividend — Nov 7, 2025

Mastercard opened new Professional Services Hubs in Warsaw and Gdańsk, aiming to double its workforce in Poland by 2028. The company launched a live-entertainment partnership with Live Nation in South Africa, giving cardholders early access to UB40 tickets. Mastercard paid a $0.76 quarterly dividend today. Shares traded at $551.5, down 0.3% intraday.
7 November 2025
····
Petrobras (PBR) jumps on Q3 results, R$12.16bn dividend and faster capex — Today, 7 November 2025

Petrobras (PBR) jumps on Q3 results, R$12.16bn dividend and faster capex — Today, 7 November 2025

Petrobras shares rose after the company reported Q3 net profit of R$32.7bn and announced R$12.16bn in interim dividends for 2025. U.S.-listed PBR ADRs gained 4.7% to $12.71 by 19:25 UTC. Management said 2025 capex is ahead of plan, with about 90% of 2026 projects already contracted. Output from the Búzios field continues to ramp up, driving record exports.
7 November 2025
····
Pfizer Stock Surges on Trump Deal & Obesity Drug Drama – Is a Comeback Coming?

Pfizer (PFE) Stock Today — Nov 7, 2025: Metsera Bidding War Intensifies, Dividend Record Date, and What’s Moving the Share Price

Pfizer shares fell 2.3% to $24.28 amid heavy trading as a Delaware judge allowed Metsera to exit its deal with Pfizer, intensifying the takeover battle with Novo Nordisk. Pfizer is reportedly considering a higher bid ahead of Metsera’s Nov. 13 shareholder vote. The company marked its dividend record date today for a $0.43 payout. Earlier this week, Pfizer raised its 2025 EPS guidance after beating Q3 estimates.
7 November 2025
····
Saudi Aramco Stock Analysis 2025: Is the Oil Giant Still Worth Your Money?

Saudi Aramco (2222.SR) — Before Market Open Today (Nov 7, 2025): Oil Rebounds But Heads for Weekly Loss, Aramco Cuts Asian OSPs, and Q3 Dividend Dates to Watch

Aramco cut December Official Selling Prices for Asia, with Arab Light set at a $1/bbl premium to Oman/Dubai and other grades reduced $1.20–$1.40/bbl. Q3 net profit fell 2.3% year-on-year to SAR 101.02bn, but adjusted net income reached $28bn, beating forecasts. Shares last closed at SAR 25.60 ahead of Sunday’s Tadawul open. Dividends for Q3 confirmed, with ex-date November 17 and payment November 26.
7 November 2025
···
Hecla Mining (HL) Soars on Record Q3 2025: $409.5M Revenue, $0.15 EPS, Dividend Declared — What to Know Today (Nov 6, 2025)

Hecla Mining (HL) Soars on Record Q3 2025: $409.5M Revenue, $0.15 EPS, Dividend Declared — What to Know Today (Nov 6, 2025)

Hecla Mining reported record Q3 revenue of $409.5 million and net income of $100.6 million, beating analyst estimates. The company tightened 2025 production guidance, announced new permitting wins, and declared dividends on both common and preferred shares. Shares surged over 10% intraday. Hecla fully repaid its revolving credit facility and ended the quarter with $133.9 million in cash.
6 November 2025
···
B2Gold (BTG) Q3 2025: Goose Mine Hits Commercial Production, Dividend Declared, Guidance Reiterated — Nov 6, 2025

B2Gold (BTG) Q3 2025: Goose Mine Hits Commercial Production, Dividend Declared, Guidance Reiterated — Nov 6, 2025

B2Gold reported Q3 gold revenue of $782.9 million and adjusted EPS of $0.14, with total production at 254,369 ounces. The Goose Mine in Nunavut reached commercial production on October 2, prompting a cut in 2025 output guidance to 50,000–80,000 ounces. Fekola Complex in Mali continues normal operations with 2025 guidance unchanged. A Q4 dividend of $0.02 per share was declared, payable December 15.
6 November 2025
···
Cummins (CMI) Q3 2025: Revenue $8.32B, Adjusted EPS $5.59; Dividend Lifted to $2.00 as Data‑Center Power Drives Beat and Accelera Faces Strategic Review

Cummins (CMI) Q3 2025: Revenue $8.32B, Adjusted EPS $5.59; Dividend Lifted to $2.00 as Data‑Center Power Drives Beat and Accelera Faces Strategic Review

Cummins reported Q3 revenue of $8.32 billion and adjusted EPS of $5.59, both above estimates, driven by strong data-center power demand. The company raised its quarterly dividend to $2.00 and launched a strategic review of its Accelera electrolyzer business after $240 million in non-cash charges. Shares rose 7.6% by midafternoon. No 2025 outlook was issued.
6 November 2025
···
ConocoPhillips (COP) beats Q3, hikes dividend 8%, lifts 2025 output; Willow budget raised to up to $9B — Nov. 6, 2025

ConocoPhillips (COP) beats Q3, hikes dividend 8%, lifts 2025 output; Willow budget raised to up to $9B — Nov. 6, 2025

ConocoPhillips beat third-quarter profit forecasts with adjusted EPS of $1.61, raised its full-year production guidance, and increased its quarterly dividend by 8% to $0.84 per share. The company cut 2025 cost guidance and set Willow project costs at $8.5–$9.0 billion. Preliminary 2026 guidance showed lower planned capital and operating costs with flat-to-modest production growth.
6 November 2025
····
Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark shares plunged 14.6% on Nov. 3 to a 52-week low near $102 after announcing a $40 billion cash-and-stock deal to acquire Kenvue at a 46% premium. The drop erased about 15% of KMB’s market value, with the stock now down 21% year-over-year. Investors cited concerns over Kenvue’s litigation risks and debt load. KMB trades at 17.3× earnings, with a 4.9% dividend yield.
4 November 2025
··
Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer shares traded at $24.65 on Nov. 3, 2025, down about 3% year-to-date and over 50% from pandemic highs. The company reports Q3 results Nov. 4, with analysts expecting $16.6 billion in revenue and $0.66 EPS. Pfizer completed a $43 billion Seagen acquisition and is in a bidding war with Novo Nordisk over Metsera. The quarterly dividend is $0.43 per share, yielding around 7%.
3 November 2025
··
Visa (V) Stock Poised for a Surge? Crypto Pilot and Travel Deals Fuel Optimism

Visa Stock Set to Soar? Analysts Eye $400 After Strong Earnings & Dividend Hike. Before Markets Open — Nov 3, 2025.

Visa closed at $340.74 on Oct. 31, 2025, near its 52-week high, up about 10% for the year. Fiscal Q4 net revenue rose 12% to $10.72 billion, with adjusted EPS of $2.98, slightly beating estimates. The company raised its quarterly dividend 14% to $0.67. Analysts maintain a bullish outlook, with price targets averaging $400 and some major banks setting targets above $410.
2 November 2025
···
Medical Properties Trust Defies Skeptics: Q3 Beat and Buyback Ignite 6%‑Yield REIT Rally

Medical Properties Trust Defies Skeptics: Q3 Beat and Buyback Ignite 6%‑Yield REIT Rally

Shares of Medical Properties Trust closed near $5.00 on Oct. 30, 2025, up 3–4% after Q3 earnings beat expectations, valuing the company at $3 billion. Management authorized a $150 million share buyback and reported improved rent collections. The REIT pays a quarterly dividend of $0.08 per share after recent cuts. Short interest remains high at 37% of float, while institutional ownership stands at 58%.
30 October 2025
··
Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

Altria reported Q3 net revenue down 3% to $6.07 billion and adjusted EPS of $1.45, matching estimates. Shares fell nearly 4% pre-market, trading about 10% below recent highs. The company doubled its buyback program to $2 billion and raised its 2025 earnings outlook floor. Cigarette and oral tobacco sales declined, while NJOY e-cigarette sales remain halted due to a patent dispute.
30 October 2025
···
1 … 37 38 39 40

Stock Market Today

  • ASML: The Tech Stock Outshining Cryptocurrency Potential
    March 22, 2026, 2:06 AM EDT. Bitcoin has fallen sharply, dropping 15.3% year to date and showing high volatility, prompting skepticism despite its headline gains. In contrast, ASML, a Dutch semiconductor equipment maker, presents a clear and tangible value proposition. ASML is the sole producer of extreme ultraviolet (EUV) lithography machines, essential for manufacturing the most advanced semiconductor chips under 7 nanometers. These machines, each worth over $400 million, underpin the global tech industry, supplying giants like TSMC, Samsung, and Nvidia. ASML's monopoly in this critical niche positions it to benefit from the expanding semiconductor market, forecast to surpass $975 billion in revenue this year. Beyond the buzz of cryptocurrency, ASML offers investors a stable, foundational play in technology manufacturing with significant growth prospects.
Go toTop